Loading…
Nanobiotix S.A. is projected to rise to $54.69 by 2027, a +36% move from its current price of $40.16. NBTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $38.70 | $40.18 | $41.72 | +0.07% |
| Aug 2 | $38.13 | $40.21 | $42.41 | +0.14% |
| Aug 3 | $37.70 | $40.24 | $42.95 | +0.21% |
| Aug 4 | $37.35 | $40.27 | $43.41 | +0.28% |
| Aug 5 | $37.05 | $40.30 | $43.83 | +0.35% |
| Aug 6 | $36.78 | $40.32 | $44.21 | +0.42% |
| Aug 7 | $36.53 | $40.35 | $44.57 | +0.49% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $36.53 | $40.35 | $44.57 | +0.49% |
| Week 2 | $35.23 | $40.55 | $46.68 | +0.99% |
| Week 3 | $34.30 | $40.75 | $48.41 | +1.49% |
| Week 4 | $33.57 | $40.95 | $49.97 | +1.99% |
| Week 5 | $32.95 | $41.16 | $51.41 | +2.49% |
| Week 6 | $32.42 | $41.36 | $52.77 | +3.00% |
| Week 7 | $31.95 | $41.56 | $54.07 | +3.51% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer.
The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand.
Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Nanobiotix S.A. (NBTX) is a healthcare stock with a current price of $40.38 and a market capitalization of $2.05B. It is ranked 1938.
The stock is currently trading in a bullish context, with technical sentiment labeled BULLISH. RSI14 is 60, SMA50 is $39.65, and SMA200 is $29.30.
The near-term setup shows a 30-day range of $30.99–$52.62, with a support level at $33.55 and a resistance at $41.64. Annualized volatility is listed at 80%.
Forecasts indicate a bullish trajectory beyond 2026, starting from a 2026 avg of $40.38 (min $19.97, max $59.87) with ROI 0 and sentiment NEUTRAL, extending into future years with rising averages and higher ROIs through 2030, 2040, and 2050 (e.g., 2030 avg $82.86, ROI 105.2%; 2040 avg $375.80, ROI 830.7%; 2050 avg $680.56, ROI 1585.4%).
A major floor 27.1% below — a decisive break under it would weaken the trend.
The nearest floor, 14.5% below — buyers have tended to step in here.
The nearest ceiling, 3.7% above — a clean break opens room to run.
A major ceiling 37.1% above — clearing it would confirm fresh momentum.
Key NBTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NBTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $39.14 | Buy | $39.14 | Buy |
| MA 10 | $38.86 | Buy | $39.05 | Buy |
| MA 20 | $39.15 | Buy | $38.80 | Buy |
| MA 50 | $38.16 | Buy | $38.09 | Buy |
| MA 100 | $36.77 | Buy | $35.69 | Buy |
| MA 200 | $29.75 | Buy | $30.07 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.25 | Neutral |
| Stoch RSI (14) | 66.06 | Neutral |
| CCI (20) | 62.88 | Neutral |
| Williams %R (14) | -25.13 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -3.57 | Sell |
| Bollinger %B (20,2) | 0.69 | Neutral |
| Stochastic %K (14) | 74.87 | Neutral |
| TRIX (15) | 0.14 | Buy |
| Awesome (5,34) | 1.23 | Buy |
| Ultimate (7,14,28) | 53.74 | Neutral |
| Momentum (10) | 2.63 | Buy |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 38.64 | Buy |
| ADX (14) | 8.80 | Neutral |
| ATR (14) | 1.36 | Info |
The near-term technical picture is bullish, with RSI14 at 60.
The price is trading above both the SMA50 ($39.65) and the SMA200 ($29.30), illustrating near-term strength.
The 30-day range sits between $30.99 and $52.62, with a support at $33.55 and a resistance at $41.64.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $19.97 | $40.16 | $58.95 | 0% | Neutral | |
| $42.12 | $54.69 | $75.92 | +36% | Bullish | |
| $44.27 | $59.85 | $87.27 | +49% | Bullish | |
| $52.56 | $73.51 | $111.31 | +83% | Bullish | |
| $58.02 | $83.63 | $130.69 | +108% | Bullish | |
| $66.40 | $98.38 | $157.99 | +145% | Bullish | |
| $92.59 | $140.79 | $231.66 | +251% | Bullish | |
| $103.25 | $160.90 | $270.62 | +301% | Bullish | |
| $111.32 | $177.61 | $304.75 | +342% | Bullish | |
| $121.52 | $198.31 | $346.64 | +394% | Bullish | |
| $205.05 | $371.65 | $701.48 | +826% | Bullish | |
| $319.97 | $701.92 | $1,478.69 | +16.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $19.97 | $40.16 | $46.98 | +0.00% |
| August 2026 | $35.89 | $42.46 | $51.65 | +5.75% |
| September 2026 | $35.78 | $42.82 | $53.04 | +0.84% |
| October 2026 | $35.39 | $42.75 | $53.71 | -0.16% |
| November 2026 | $36.68 | $44.66 | $56.76 | +4.46% |
| December 2026 | $37.44 | $45.90 | $58.95 | +2.79% |
Click any year to see its month-by-month NBTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, NBTX is projected to trade between $19.97 and $58.95, averaging $40.16 — a potential gain of 0% from today's $40.16. A consolidation phase looks the most probable path here.
Nanobiotix S.A.'s 2027 outlook centres on $54.69, within a $42.12 to $75.92 range. That is up +36% on the projected 2026 average. That marks a +36% change versus current levels. Momentum favours further upside here.
By 2028, NBTX could reach as high as $87.27, with a base case around $59.85 and support toward $44.27 — roughly +49% from $40.16. Buyers look set to stay in control over this stretch.
Expect NBTX to range from $52.56 to $111.31 through 2029. The $73.51 average target implies a +83% move from current prices. That is up +23% on the projected 2028 average. Momentum favours further upside here.
The NBTX price prediction for 2030 points to an average of $83.63 (low $58.02, high $130.69) — a potential gain of +108% on today's $40.16. Buyers look set to stay in control over this stretch.
In 2031, NBTX is projected to trade between $66.40 and $157.99, averaging $98.38 — a potential gain of +145% from today's $40.16. That is up +18% on the projected 2030 average. Momentum favours further upside here.
Nanobiotix S.A.'s 2032 outlook centres on $140.79, within a $92.59 to $231.66 range. That is up +43% on the projected 2031 average. That marks a +251% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, NBTX could reach as high as $270.62, with a base case around $160.90 and support toward $103.25 — roughly +301% from $40.16. Momentum favours further upside here.
Expect NBTX to range from $111.32 to $304.75 through 2034. The $177.61 average target implies a +342% move from current prices. That is up +10% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The NBTX price prediction for 2035 points to an average of $198.31 (low $121.52, high $346.64) — a potential gain of +394% on today's $40.16. Momentum favours further upside here.
In 2040, NBTX is projected to trade between $205.05 and $701.48, averaging $371.65 — a potential gain of +826% from today's $40.16. That is up +87% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Nanobiotix S.A.'s 2050 outlook centres on $701.92, within a $319.97 to $1,478.69 range. That is up +89% on the projected 2040 average. That marks a +16.5x change versus current levels. Momentum favours further upside here.
Investing $1,000 in NBTX today (≈ 24.903499 NBTX) could be worth
$17,480.32
+$16,480.32 (+1648%) by 2050 · US Dollar
Based on the average projected NBTX price of $701.92 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NBTXwould be worth at today's price.
$1,000 invested in NBTX on Jul 30, 2025 (≈ 149.588633 NBTX) would be worth
$6,006.73
+$5,006.73 (+500.7%) today · 6.01× · US Dollar
Based on a NBTX entry price of $6.68 vs. today's $40.16.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $39.55 | $1,015.3 | +1.5% |
| 1 month ago | $37.7 | $1,065.12 | +6.5% |
| 3 months ago | $35.12 | $1,143.37 | +14.3% |
| 6 months ago | $21 | $1,912.14 | +91.2% |
| 1 year ago | $6.68 | $6,006.73 | +500.7% |
| All time (5.0y) ago | $14.1 | $2,847.87 | +184.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NBTX forecast.
Our base-case forecast reaches $80.00 around 2030.
Implied market cap at $80.00: $4.06B
The multi-year forecast shows a strong bullish trajectory, with the 2026 average price at $40.38 and rising to $82.86 by 2030, $375.80 by 2040, and $680.56 by 2050.
ROI is projected to climb from 0% in 2026 to 105.2% by 2030, 830.7% by 2040, and 1585.4% by 2050, with sentiment labeled BULLISH in 2030 and beyond.
These projections imply meaningful upside over the long term, subject to the usual uncertainties that accompany forecasts. The figures are estimates, not guarantees.
Tap a question to reveal the answer.
2030 avg $82.86; min $56.44; max $131.86; ROI 105.2%; sentiment BULLISH.
Forecasts show a bullish trajectory from 2027 onward with rising averages and ROIs (e.g., 2027 ROI 36.2%, 2030 ROI 105.2%, 2040 ROI 830.7%, 2050 ROI 1585.4%), though 2026 is neutral. These are estimates, not guarantees.
Yes. The 2050 max is $1,478.24 with an expected ROI of 1585.4% and a bullish sentiment.
Current price $40.38; Market Cap $2.05B; Rank 1938.
2040 min $199.03; avg $375.80; max $728.31; ROI 830.7%; sentiment BULLISH.
Nanobiotix S.A. Community Discussion
0Share your Nanobiotix S.A. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.